http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2012008360-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
filingDate 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f350baba411c88abf2ff60f3b0c191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b71b152bcaef053eb1d4fc820c5f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c9fb4cb121ddb9134e8f3eec275574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42457ccdc753098441bad732a4fe369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa62d16b65ab4e21e0a7560ab317b64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb97f53a376f62879eb39f6568d036f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeea5ba7e443d5d4b60780bea3844699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd3b0f98cfb62c041c02314151fcb5f
publicationDate 2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2012008360-A
titleOfInvention ANTICOAGULANTS ANTIDOTES.
abstract The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of said anticoagulants.
priorityDate 2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210

Total number of triples: 39.